Last update : MERCURY™ v3.0
We are delighted to present the latest version of MERCURY (v3.0). This release includes a number of updates and new features designed to enhance MERCURY's analysis capabilities and improve your user experience.
MERCURY v3.0's performance has been enhanced at both analysis pipeline and annotation levels. This includes:
- Detection of constitutional variants in tumor samples as part of normal/tumor pair analysis, enabling the identification of variant enrichment in LOH regions
- Increased number of identifiable mutation signatures - 67 SBS (Single Base Substitution) signatures now available
- Optimizing fusion transcript analysis :
- Update of fusion transcript detection pipeline and annotation databases - update of Trinity Cancer Transcriptome Toolkit (CTAT v1.7.0) and GENCODE v31 database
- New graphical representations for fusion analysis
- Improved graphic representations of the circos plot and allelic frequency (BAF)
- Updating and adding filters for improved classification and selection of variants
Click here to access the full release notes for the new version of MERCURY (v3.0)
To find out more, go to www.mercury-oncology.com
.
MERCURY™is now customizable for analysis of large and small gene panels
Fully adaptable to your needs, MERCURY can now analyze your WES, RNA-seq or WGS sequencing data, as well as your gene panel data. Whether you're using a ready-to-use panel or one you've developed yourself, IntegraGen will help you fine-tune your analysis pipelines and adapt your clinical reports.
Find out how MERCURY can meet your needs, or request a free demo, contact us.
.
June 10, 2020
Share :
Leave a Reply